Administration of BAY 41-2272 prevents bladder dysfunction in nitric-oxide deficient rats
Objective: to evaluate the protective effects of BAY 41-2272, asoluble guanylate cyclase activator, on changes in cystometricparameters in rats deficient in nitric oxide (NO). Methods: Ratswere divided into the following groups: (a) control; (b) DMSO; (c)L-NAME; (d) BAY 41-2272 alone; (e) L-NAME + B...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2010-12-01
|
Series: | Einstein (São Paulo) |
Subjects: | |
Online Access: | http://apps.einstein.br/revista/arquivos/PDF/1789-Einsteinv8n4_pg404-409_eng.pdf |